Cardiovascular risk in 159 934 frequent blood donors while addressing the healthy donor effect

Karlijn Peffer1, Martin den Heijer2, Wim L A M de Kort1,3

  • 1Department of Donor Medicine Research - Donor Studies, Sanquin Research, Amsterdam, The Netherlands.

Insights

Regular blood donation may reduce cardiovascular disease risk in women. This study found that long-term, high-frequency blood donation was associated with lower cardiovascular morbidity in females but not in males.

Area of Science:

  • Cardiovascular Health
  • Hematology
  • Public Health

Background:

  • Cardiovascular disease remains a leading cause of mortality worldwide.
  • Blood donation is a common practice aimed at ensuring adequate blood supply for medical needs.
  • The potential health benefits or risks for blood donors themselves are an area of ongoing research.

Purpose of the Study:

  • To investigate the association between regular blood donation and the risk of developing cardiovascular disease.
  • To determine if there is a sex-specific difference in the cardiovascular risk associated with blood donation.

Main Methods:

  • A cohort of 159,934 Dutch whole-blood donors with at least 10 years of donation history was analyzed.
  • Donors were categorized into tertiles based on donation frequency.
  • Cardiovascular endpoints were assessed using hospital discharge diagnoses and death certificates, with Cox regression used for analysis.

Main Results:

  • Female high-frequency blood donors exhibited reduced cardiovascular morbidity compared to low-frequency donors (HRR=0.91).
  • No significant association between blood donation frequency and cardiovascular risk was observed in men (HRR=1.00).
  • Sensitivity analyses using a shorter qualification period supported the absence of a residual healthy donor effect.

Conclusions:

  • Long-term, high-frequency blood donation appears to have a protective effect against cardiovascular disease.
  • This protective association was specifically observed in women, with no effect noted in men.
  • The findings suggest a potential benefit of regular blood donation for cardiovascular health in females.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
840
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
383
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
605
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
574
Overview of the Cardiovascular System01:14

Overview of the Cardiovascular System

The cardiovascular system is a vital transportation system in the body. It comprises the heart and blood vessels and facilitates the exchange of gases, nutrients, and waste products.
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
11.7K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K